Related Experiment Video

Updated: Mar 22, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

Common Questions in Anticoagulation Management in Atrial Fibrillation

Pilar Gallego1, Vanessa Roldán2, Gregory Y H Lip3

  • 1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham, B18 7QH, UK; Department of Hematology and Clinical Oncology, Hospital Universitario Morales Meseguer, Avda. Marqués de los Velez s/n. 30004 Murcia, Spain.

Cardiac Electrophysiology Clinics
|April 12, 2016
PubMed

Insights

Novel oral anticoagulants (NOACs) offer benefits over vitamin K antagonists (VKAs) for patients with poor anticoagulation control. This article discusses managing NOACs, focusing on bleeding complications and urgent care needs.

Area of Science:

  • Pharmacology
  • Cardiology
  • Neurology

Background:

  • Vitamin K antagonists (VKAs) have limitations in anticoagulation control.
  • Novel oral anticoagulants (NOACs) have been developed to improve patient outcomes.
  • The SAMe-TT2R2 score aids in predicting anticoagulation control with VKAs.

Purpose of the Study:

  • To review the benefits of NOACs compared to VKAs.
  • To outline the management of bleeding complications associated with NOACs.
  • To address clinical scenarios requiring urgent management in patients on anticoagulation therapy.

Main Methods:

  • Review of clinical trials and guidelines.
  • Analysis of bleeding risk and management strategies.
  • Discussion of specific patient populations and urgent care situations.

Main Results:

  • NOACs demonstrate a significant reduction in hemorrhagic stroke and intracranial bleeding compared to VKAs.
  • Effective management strategies for bleeding complications are crucial.
  • Preparedness for urgent surgical or thrombolytic interventions is necessary.

Conclusions:

  • NOACs represent a significant advancement in anticoagulant therapy.
  • Clinicians must be adept at managing NOAC-related bleeding and urgent care situations.
  • Optimizing anticoagulation management improves patient safety and outcomes.
Keywords:
Atrial fibrillationChronic anticoagulation managementNew oral anticoagulants

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
366
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
545
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
610